Published in J Clin Oncol on February 16, 2010
The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause (2012) 4.04
Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med (2011) 2.77
Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.77
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst (2010) 1.31
Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev (2011) 1.20
Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res (2010) 1.17
Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev (2010) 1.10
Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women. Carcinogenesis (2010) 1.07
Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer. Steroids (2011) 0.98
Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer. Lung Cancer (2011) 0.94
Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small-cell lung cancer. J Thorac Oncol (2013) 0.91
Estrongenic steroid hormones in lung cancer. Semin Oncol (2013) 0.89
Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study. Int J Cancer (2012) 0.89
Lung cancer in women: role of estrogens. Expert Rev Respir Med (2010) 0.88
Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer (2011) 0.88
Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma. Int J Clin Exp Pathol (2012) 0.86
Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Br J Cancer (2013) 0.86
Hormonal Replacement Therapy and the Risk of Lung Cancer in Women: An Adaptive Meta-analysis of Cohort Studies. J Prev Med Public Health (2015) 0.86
Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens. Carcinogenesis (2012) 0.86
The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer. Lung Cancer Manag (2012) 0.85
Invited commentary: the etiology of lung cancer in men compared with women. Am J Epidemiol (2013) 0.85
Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. Environ Health (2012) 0.84
Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis. PLoS One (2013) 0.84
Smoking out reproductive hormone actions in lung cancer. Mol Cancer Res (2014) 0.83
Mechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytes. Glia (2014) 0.82
Use of the cytokinesis-blocked micronucleus assay to detect gender differences and genetic instability in a lung cancer case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.81
Estrogen signaling in lung cancer: an opportunity for novel therapy. Cancers (Basel) (2012) 0.81
Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control (2012) 0.80
Lung cancer in never smokers in the UK Million Women Study. Int J Cancer (2016) 0.80
Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies. J Thorac Oncol (2015) 0.78
Correlation between epidermal growth factor receptor mutations and nuclear expression of female hormone receptors in non-small cell lung cancer: a meta-analysis. J Thorac Dis (2015) 0.78
Targeting Estrogen Receptor Signaling with Fulvestrant Enhances Immune and Chemotherapy-Mediated Cytotoxicity of Human Lung Cancer. Clin Cancer Res (2016) 0.77
Targeting the estrogen pathway for the treatment and prevention of lung cancer. Lung Cancer Manag (2014) 0.77
Significance of the progesterone receptor and epidermal growth factor receptor, but not the estrogen receptor, in chemically induced lung carcinogenesis in female A/J mice. Oncol Lett (2014) 0.76
Women Epidemiology Lung Cancer (WELCA) study: reproductive, hormonal, occupational risk factors and biobank. BMC Public Health (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med (1994) 16.96
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ (2000) 11.35
Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol (1999) 10.36
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med (1996) 10.09
National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA (2004) 7.68
Cigarette smoking among adults--United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 6.82
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet (2009) 5.22
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA (2008) 4.42
VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol (2004) 3.97
Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer (1995) 3.78
Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations. Am J Epidemiol (1997) 3.57
Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst (2004) 3.51
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol (2005) 2.88
Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst (1999) 2.68
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res (2002) 2.52
Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol (2003) 2.38
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res (2005) 2.28
Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids (2007) 1.80
Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst (1994) 1.74
Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol (2007) 1.62
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation. Clin Cancer Res (2009) 1.60
Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res (2004) 1.57
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids (2005) 1.57
Lung cancer in women: emerging differences in epidemiology, biology, and therapy. Chest (2005) 1.55
Risk of cancer in women receiving hormone replacement therapy. Int J Cancer (1989) 1.49
Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer (2005) 1.49
Hormonal factors and risk of lung cancer among women? Int J Epidemiol (2003) 1.42
Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer (2008) 1.34
Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer (2007) 1.24
Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev (2008) 1.24
Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer (2006) 1.22
Estrogen and its receptors in cancer. Med Res Rev (2008) 1.16
Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis (2009) 1.16
Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception (2005) 1.11
Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Oncology (2008) 1.11
Hormone replacement therapy and lung cancer risk in Chinese. Cancer (2007) 1.09
Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol (2003) 1.08
Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf (2002) 1.00
Olestra Postmarketing Surveillance Study: design and baseline results from the sentinel site. J Am Diet Assoc (1998) 1.00
Dietary boron and hormone replacement therapy as risk factors for lung cancer in women. Am J Epidemiol (2008) 0.91
Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest (2007) 0.86
Summaries for patients. Hormone therapy to prevent chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med (2005) 0.81
Methodologic challenges in chronic disease population research. Biostatistics (2001) 0.77
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol (2013) 7.97
The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol (2003) 7.49
Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med (2010) 7.20
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med (2012) 6.77
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet (2009) 5.22
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Recreational physical activity and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA (2003) 4.72
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med (2008) 4.16
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 4.15
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant (2006) 4.09
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med (2008) 3.60
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27
Hormone replacement therapy in relation to breast cancer. JAMA (2002) 3.14
Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst (2013) 2.99
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
Factors contributing to mammography failure in women aged 40-49 years. J Natl Cancer Inst (2004) 2.84
Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA (2008) 2.73
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res (2003) 2.49
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol Blood Marrow Transplant (2006) 2.44
Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol (2003) 2.38
Cardiovascular events associated with ipratropium bromide in COPD. Chest (2009) 2.36
Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res (2008) 2.13
Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med (2014) 2.08
Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med (2014) 2.07
Risk factors for triple-negative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev (2009) 2.00
Screening mammography: clinical image quality and the risk of interval breast cancer. AJR Am J Roentgenol (2002) 1.97
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Alcohol screening scores and medication nonadherence. Ann Intern Med (2008) 1.94
Buccal cell DNA yield, quality, and collection costs: comparison of methods for large-scale studies. Cancer Epidemiol Biomarkers Prev (2002) 1.92
A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med (2006) 1.91
A comprehensive examination of health conditions associated with obesity in older adults. Am J Prev Med (2004) 1.89
Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA (2009) 1.88
Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev (2004) 1.82
Yoga practice is associated with attenuated weight gain in healthy, middle-aged men and women. Altern Ther Health Med (2005) 1.79
Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med (2003) 1.77
Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. Am J Clin Nutr (2007) 1.76
Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol (2011) 1.71
Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One (2013) 1.71
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. J Clin Oncol (2011) 1.70
A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care (2007) 1.69
Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69
Low birth weight and respiratory disease in adulthood: a population-based case-control study. Am J Respir Crit Care Med (2009) 1.68
Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol (2009) 1.63
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol (2009) 1.63
Risk factors for renal cell carcinoma in the VITAL study. J Urol (2013) 1.62
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res (2011) 1.62
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.53
Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol (2011) 1.52
Regional variation in health status among chronic obstructive pulmonary disease patients. Respiration (2010) 1.52
Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med (2004) 1.52
The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest (2014) 1.51
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med (2013) 1.51
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Test-retest reliability of the Women's Health Initiative physical activity questionnaire. Med Sci Sports Exerc (2009) 1.48
Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respir Care (2009) 1.46
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med (2010) 1.45
Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol (2009) 1.44
Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2010) 1.44
Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol (2009) 1.42
Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2013) 1.42
Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med (2005) 1.41
Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT. J Infect Dis (2010) 1.36
Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med (2012) 1.33
Genetic testing for dilated cardiomyopathy in clinical practice. J Card Fail (2012) 1.32
Poverty, obesity, and malnutrition: an international perspective recognizing the paradox. J Am Diet Assoc (2007) 1.32
Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms. AJR Am J Roentgenol (2002) 1.32
Assessment of a one-page questionnaire on long-term recreational physical activity. Epidemiology (2004) 1.32
Selection bias in the assessment of gene-environment interaction in case-control studies. Am J Epidemiol (2003) 1.31
Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst (2010) 1.31
Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control (2004) 1.30
Reliability and validity of 2 single-item measures of psychosocial stress. Epidemiology (2006) 1.30
Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses. J Infect Dis (2006) 1.29
Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr (2008) 1.26
Associations of psychosocial factors with fruit and vegetable intake among African-Americans. Public Health Nutr (2007) 1.26
Plasminogen alleles influence susceptibility to invasive aspergillosis. PLoS Genet (2008) 1.25
Anthropometrics and prostate cancer risk. Am J Epidemiol (2007) 1.25
Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev (2007) 1.25
Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report. Am J Respir Crit Care Med (2012) 1.25
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. Blood (2012) 1.22
Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control (2007) 1.22
An official American Thoracic Society policy statement: pay-for-performance in pulmonary, critical care, and sleep medicine. Am J Respir Crit Care Med (2010) 1.20
Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer (2005) 1.19
Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.18
A novel custom resequencing array for dilated cardiomyopathy. Genet Med (2010) 1.18
Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med (2004) 1.18